Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 04, 2016 16:05 ET | Source: Esperion Therapeutics, Inc.

Esperion Therapeutics Provides Bempedoic Acid Development Program Updates; Reports Second Quarter 2016 Financial Results

ANN ARBOR, Mich., Aug. 04, 2016 (GLOBE NEWSWIRE) -- Esperion Therapeutics, Inc. (NASDAQ:ESPR), a pharmaceutical company focused on developing and commercializing oral therapies for the treatment...
August 04, 2016 07:09 ET | Source: ANSYS, Inc.

ANSYS, Inc. Reports Q2 2016 Financial Results Highlighting Solid Revenue, Margin and EPS Performance

Quarterly Highlights: GAAP and non-GAAP revenue of $246.1 million GAAP diluted earnings per share of $0.78 and non-GAAP diluted earnings per share of $0.93GAAP operating profit margin of 38.3% and...